TY  - JOUR
AU  - Piñana, José Luis
AU  - Vázquez, Lourdes
AU  - Martino, Rodrigo
AU  - de la Cámara, Rafael
AU  - Sureda, Anna
AU  - Rodríguez-Veiga, Rebeca
AU  - Garrido, Ana
AU  - Sierra, Jorge
AU  - Ribera, José-María
AU  - Torrent, Anna
AU  - Mateos, María Victoria
AU  - de la Rubia, Javier
AU  - Tormo, Mar
AU  - Díez-Campelo, María
AU  - García-Gutiérrez, Valentín
AU  - Álvarez-Larrán, Alberto
AU  - Sancho, Juan-Manuel
AU  - MartínGarcía-Sancho, Alejandro
AU  - Yañez, Lucrecia
AU  - Pérez Simón, José Antonio
AU  - Barba, Pere
AU  - Abrisqueta, Pau
AU  - Álvarez-Twose, Iván
AU  - Bonanad, Santiago
AU  - Lecumberri, Ramón
AU  - Ruiz-Camps, Isabel
AU  - Navarro, David
AU  - Hernández-Rivas, José-Ángel
AU  - Cedillo, Ángel
AU  - García-Sanz, Ramón
AU  - Bosch, Francesc
PY  - 2021
DO  - 10.1080/10428194.2021.1992619
UR  - https://hdl.handle.net/10668/27272
T2  - Leukemia & lymphoma
AB  - In the midst of the COVID-19 pandemic, different vaccines in front of SARS-CoV-2 have been approved and administered in different vulnerable populations. As patients with cancer were excluded from pivotal trials of vaccination, little is known on...
LA  - en
KW  - COVID-19
KW  - SARS-CoV-2 vaccine
KW  - acute leukemia
KW  - allogeneic stem cell transplantation
KW  - lymphoma
KW  - myelodisplastic syndrome
KW  - myeloproliferative neoplasm
KW  - onco-hematology
KW  - stem cell transplantation
KW  - vaccination consensus
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - Consensus
KW  - Expert Testimony
KW  - Hematology
KW  - Humans
KW  - Pandemics
KW  - SARS-CoV-2
KW  - Vaccination
TI  - Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
TY  - research article
VL  - 63
ER  -